西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2015年
4期
7-10
,共4页
腰痛,慢性%杜仲腰痛丸%随机对照%临床试验
腰痛,慢性%杜仲腰痛汍%隨機對照%臨床試驗
요통,만성%두중요통환%수궤대조%림상시험
chronic lumbago%DuZhongYaoTongpill%randomized control%clinical trial
目的：观察杜仲腰痛丸治疗慢性腰痛和预防复发的临床疗效。方法：将98例慢性腰痛患者，按照1∶1比例完全随机分为2组。对照组49例给予常规治疗；观察组49例给予常规治疗联合杜仲腰痛丸治疗，2组均连续治疗4周。所有患者分别于治疗前、治疗后1个月、3个月、6个月统计疼痛视觉模拟评分(VAS)、Oswstry功能障碍指数(CODI)值，随访复发情况。结果：2组治疗后VAS、CODI评分较治疗前均明显降低（P＜0.05）；组内比较，对照组治疗3个月、6个月VAS、CODI评分比较，差异无统计学意义（P＞0.05），观察组在不同时间比较，差异均无统计学意义（P＜0.05）；组间比较，2组在治疗1个月VAS、CODI评分比较，差异无统计学意义（P＞0.05），而治疗3个月、6个月比较差异有统计学意义（P＜0.05）。观察组的复发率低于对照组（P＜0.05）。结论：杜仲腰痛丸能增强慢性腰痛的长期治疗效果，包括减轻疼痛症状，改善腰部功能活动，并能预防慢性腰痛的复发。
目的：觀察杜仲腰痛汍治療慢性腰痛和預防複髮的臨床療效。方法：將98例慢性腰痛患者，按照1∶1比例完全隨機分為2組。對照組49例給予常規治療；觀察組49例給予常規治療聯閤杜仲腰痛汍治療，2組均連續治療4週。所有患者分彆于治療前、治療後1箇月、3箇月、6箇月統計疼痛視覺模擬評分(VAS)、Oswstry功能障礙指數(CODI)值，隨訪複髮情況。結果：2組治療後VAS、CODI評分較治療前均明顯降低（P＜0.05）；組內比較，對照組治療3箇月、6箇月VAS、CODI評分比較，差異無統計學意義（P＞0.05），觀察組在不同時間比較，差異均無統計學意義（P＜0.05）；組間比較，2組在治療1箇月VAS、CODI評分比較，差異無統計學意義（P＞0.05），而治療3箇月、6箇月比較差異有統計學意義（P＜0.05）。觀察組的複髮率低于對照組（P＜0.05）。結論：杜仲腰痛汍能增彊慢性腰痛的長期治療效果，包括減輕疼痛癥狀，改善腰部功能活動，併能預防慢性腰痛的複髮。
목적：관찰두중요통환치료만성요통화예방복발적림상료효。방법：장98례만성요통환자，안조1∶1비례완전수궤분위2조。대조조49례급여상규치료；관찰조49례급여상규치료연합두중요통환치료，2조균련속치료4주。소유환자분별우치료전、치료후1개월、3개월、6개월통계동통시각모의평분(VAS)、Oswstry공능장애지수(CODI)치，수방복발정황。결과：2조치료후VAS、CODI평분교치료전균명현강저（P＜0.05）；조내비교，대조조치료3개월、6개월VAS、CODI평분비교，차이무통계학의의（P＞0.05），관찰조재불동시간비교，차이균무통계학의의（P＜0.05）；조간비교，2조재치료1개월VAS、CODI평분비교，차이무통계학의의（P＞0.05），이치료3개월、6개월비교차이유통계학의의（P＜0.05）。관찰조적복발솔저우대조조（P＜0.05）。결론：두중요통환능증강만성요통적장기치료효과，포괄감경동통증상，개선요부공능활동，병능예방만성요통적복발。
To observe the clinical efficacy ofDuZhongYaoTongpill in treating chronic lumbago and preventing relapse. Methods: Totally 98 patients with chronic lumbago were randomly assigned to two groups on average. 49 cases in the control group were treated with routine therapy for four weeks continuously, as well as the observation group undergoing routine therapy andDuZhongYaoTongpill. VAS and CODI of all the cases were eval-uated respectively before treatment and at the end of 1st, 3rd and 6th month with follow-up of relapse. Results: The scores of VAS and CODI decreased significantly after treatment (P<0.05) in both groups. The comparison of these scores in the control group showed that the difference before and after treatment at 3rd and 6th month had no statis-tical meaning(P<0.05), so did the observation group in each times(P<0.05). In the comparison of scores in 1st month between two groups had no statistical meaning, while there was statistical meaning at 3rd and 6th month. The recurrence rate of the observation group turned out to be lower than that of the control group. Conclusion:DuZhong YaoTongpill could enhance the therapeutic effect of chronic lumbago, which includes relieving pain of patients, im-proving the functional activity of the waist and preventing the relapse of chronic lumbago.
